【24h】

UVA System for Human Cornea Irradiation

机译:人体角膜照射的UVA系统

获取原文
获取原文并翻译 | 示例

摘要

According to recent studies, an increase in corneal stiffness is a promising alternative for avoiding ectasias and for stagnating keratoconus of grades 1 and 2. The clinical treatment consists essentially of instilling Riboflavin (vitamin B2), in the cornea and then irradiating the corneal tissue, with UVA (365nm) radiation at 3mW/cm~2 for 30min. This procedure provides collagen cross-linking in the corneal surface, increasing its stiffness. This work presents a system for UVA irradiation of the corneas at a peak wavelength of 365nm with adjustable power up to 5m W. The system has closed loop electronics to control the emitted power with 20% precision from the sated power output. The system is a prototype for performing corneal cross-linking and has been clinically tested. The closed loop electronics is a differential from the equipments available on the market.
机译:根据最近的研究,增加角膜刚度是避免出现扩张和停滞1和2级圆锥角膜的一种有前途的选择。临床治疗主要包括在角膜中注入核黄素(维生素B2),然后照射角膜组织,以3mW / cm〜2的UVA(365nm)辐射30分钟。此过程可在角膜表面提供胶原蛋白交联,增加其硬度。这项工作提出了一种在365nm峰值波长处对UVA照射角膜的系统,可调节功率高达5mW。该系统具有闭环电子设备,可以以额定功率输出的20%精度控制发射功率。该系统是用于执行角膜交联的原型,并且已经过临床测试。闭环电子设备与市场上的设备有所不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号